Medway School of Pharmacy

Medway School of Pharmacy

Medical examination in a doctor's room

Pharmacy (Biochemistry and Cell Biology) - PhD

2024

Our research programme in Pharmacy gives you the integrated, broad-based research training needed to exploit current advances in pharmaceutical and biological sciences and pharmacy practice.

2024

Overview

Within the school we have a number of home, EU and international postgraduate students who are undertaking doctoral research degrees. Graduates who obtain their PhD from Kent or Greenwich are highly sought after by prospective employers, both within the UK and overseas. Destinations for doctoral graduates include university academic departments, research institutes and leading pharmaceutical and biotechnological companies.

About Medway School of Pharmacy

Medway School of Pharmacy is one of the few regional schools of pharmacy in the UK, a collaboration between the University of Kent and the University of Greenwich.

The impetus for the formation of the Medway School of Pharmacy came from the local community, who recognised the shortage of qualified pharmacists in all branches of the pharmacy profession in Kent.

The School is now recognised as an established school with accreditation from the General Pharmaceutical Council (GPhC) and the Health and Care Professions Council (HCPC). Graduates are employed in health disciplines in Kent and the south-east and more broadly across the UK.

National ratings

In the Research Excellence Framework (REF) 2021, over 85% of our Allied health professions, dentistry, nursing and pharmacy research* was classified as ‘world-leading’ or ‘internationally excellent’ for output and environment.

* Joint submission with University of Greenwich.

Project Titles Supervisors
Circadian Rhythms and Aging Dr Gurprit Lall, Dr Aiste Steponenaite
Selection and evaluation of new universal influenza vaccine candidates using monoclonal antibodies and digitally designed HA and NA libraries & pseudotype virus screens Dr Nigel Temperton, Dr Simon Scott , Prof Jonathan Heeney (University of Cambridge)
Generation of human cytomegalovirus-pseudotyped particles and development of systems for the study of viral cell entry mechanisms, neutralizing antibody responses to infection and vaccination, and testing of potential novel therapeutics Dr Simon Scott , Dr Nigel Temperton, Dr Matthew Reeves (UCL)
The Creation of Anti-Viral Plastic Nanobodies for Diagnostics and Therapeutics via Molecular Imprinting of Synthetic Polymers Dr Andrew J Hall, Dr Nigel Temperton
Deciphering the landscape of nucleoporin and lamin function in nucleocytoplasmic communication, nuclear scaffolding and transcriptional control in disease prevention Dr Fani Papagiannouli, Dr Gurprit Lall
Cross-modal sensory integration for motor decision making. Dr Stella Koutsikou, Dr Tobias von der Haar
Development of lipid-polymer hybrid nanoparticles via microfluidics, for the intracellular delivery of nucleic acid therapeutics Dr Nathalie Lavignac, Dr Vladimir Gubala
Cross-talks of immune checkpoint pathways determine the abilities of human malignant tumours to suppress cytotoxic attacks and escape immune surveillance Dr Vadim V Sumbayev
Understanding the link between head injuries and Alzheimer's disease. Dr Romina Vuono